
Image sourced from Shutterstock
Incyte (NASDAQ:INCY) has had a good run so far this year. It is one of the few biotech stocks that has outperformed the industry in this time frame.

Image sourced from Shutterstock
Incyte (NASDAQ:INCY) has had a good run so far this year. It is one of the few biotech stocks that has outperformed the industry in this time frame.